title: Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands mm.smits1@vumc.nl.
authors.forename: Mark M
authors.initials: MM
authors.lastname: Smits
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands Eli Lilly and Co., Utrecht, the Netherlands.
authors.forename: Mathijs C
authors.identifier: http://orcid.org/0000-0001-8236-8842
authors.initials: MC
authors.lastname: Bunck
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Michaela
authors.initials: M
authors.lastname: Diamant
authors.affiliation: Faculty of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
authors.forename: Anja
authors.initials: A
authors.lastname: Corner
authors.affiliation: Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: Bjorn
authors.initials: B
authors.lastname: Eliasson
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands Eli Lilly and Co., Indianapolis, IN.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Heine
authors.affiliation: Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: Ulf
authors.initials: U
authors.lastname: Smith
authors.affiliation: Faculty of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
authors.forename: Hannele
authors.initials: H
authors.lastname: Yki-Järvinen
authors.affiliation: Diabetes Center, Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Daniël H
authors.initials: DH
authors.lastname: van Raalte